Latest on Pharmaceutical Industry


Allergan Partners with TARGET PharmaSolutions to Advance NASH Research

Allergan, a leading global biopharmaceutical company, announced today that it will collaborate with TARGET PharmaSolutions, a clinical data company focused on real world evidence, on its TARGET-NASH study. TARGET-NASH is..Read More...

Aldeyra Therapeutics receives orphan drug designation from FDA

Aldeyra Therapeutics Inc receives orphan drug designation from the U.S. Food And Drug Administration for ADX-102 in sjögren-larsson syndrome. Aldeyra Therapeutics Inc- FDA granted Aldeyra's novel compound ADX-102..Read More...



10th Annual Proteins & Antibodies Congress

Novotel London West,
United Kingdom,
Oxford Global Marketing Ltd


4th Annual Peptides Congress

Novotel London West,
United Kingdom,
Oxford Global Marketing Ltd

Press Releases

Lonza Unveils Agenda for 3rd Annual Global Endotoxin Testing Summit

A growing list of experts from the global bacterial endotoxin testing community has signed up to join the speaker panel at Lonzas 3rd Global Endotoxin Testing Summit 57 June 2017 Annapolis MD and Pickering Beach DE USA .. Read More...

Oramed Granted European Patent for Combination Oral Insulin and GLP-1 Analog Capsule

Oramed Pharmaceuticals Inc a clinicalstage pharmaceutical company focused on the development of oral drug delivery systems announced today that the European Patent Office has granted the Company a patent titled Methods a.. Read More...

Suppliers of the Month

Product Launch



Latest Reports


Latest Projects


Expert Talk

Bayer Pharmaceuticals

Bayer Pharmaceuticals Christoph Huwe PhD CAAM is a Strategic Alliance Manager Therapeutics at Bayer AG Pharmaceuticals with a focus on the BayerEvotec Endometriosis BayerEvotec Kidney Diseases BayerOncoMed Oncology strategic alliances and the Tuberculosis Drug Accelerator consortium He is also a member of Bayers Alliance. Read More...
Christoph Huwe
Strategic Alliance Manager Therapeutics